With DCGI Nod in hand, Roche launches Breast Cancer Drug Atezolizumab in India Medical Dialogues Bureau9 April 2020 12:30 PM ISTNew Delhi: Drug firm Roche India on Wednesday said it has launched immunotherapy drug Atezolizumab for the treatment of metastatic triple-negative...
Coronavirus Outbreak: Govt to grant licence to industrial manufacturers to produce oxygen for medical use Medical Dialogues Bureau8 April 2020 10:00 AM ISTNew Delhi: The Drug Controller General of India (DCGI) has decided to grant a licence to manufacturers of industrial oxygen to produce oxygen for...
BAN on export of anti-malarial drug hydroxycloroquine with immediate effect: Govt Medical Dialogues Bureau26 March 2020 12:27 PM IST"The export of hydroxycloroquine and formulations made from hydroxycloroquine is prohibited with immediate effect".
CDSCO issues regulatory pathway for R&D of IVD kit for diagnosis of COVID-19 Medical Dialogues Bureau24 March 2020 11:45 AM ISTDelhi: Through the recent notice Central Drugs Standard Control Organization(CDSCO), Directorate General of Health Services as apprised about the...
CDSCO to fast-track applications, issues regulatory pathway for R & D of drugs for COVID-19 Medical Dialogues Bureau22 March 2020 12:15 PM ISTDelhi: Through a recent notice Central Drugs Standard Control Organization(CDSCO) , Directorate General of Health Services has released the regulatory...
CDSCO issues clarification on the requirement of process validation report for permission to conduct Clinical trial/BA-BE studies Medical Dialogues Bureau21 March 2020 12:00 PM ISTNew Delhi: Through a recent notice Central Drugs Standard Control Organization (CDSC0), Directorate General of Health Services has clarified the...
Roche Diagnostics India first private firm to get COVID-19 test approval Medical Dialogues Bureau20 March 2020 10:00 AM ISTNew Delhi: Roche Diagnostics India has received the license from the country's drug regulator DCGI for its ''Cobas SARS CoV-2'' diagnostic test kit,...
CDSCO updates procedure for issuance of WHO GMP Medical Dialogues Bureau15 March 2020 12:45 PM ISTNew Delhi: Through a recent notice Central Drugs Standard Control Organization (CDSC0), Directorate General of Health Services, has laid...
AstraZeneca Pharma India gets DCGI nod for Calquence-Acalabrutinib 100mg capsules Medical Dialogues Bureau14 March 2020 12:03 PM ISTAcalabrutinib 100mg capsules are indicated for the treatment of patients with chronic lymphocytic leukaemia (CLL)/ small lymphocytic lymphoma (SLL).
CDSCO updates FAQs Drugs & Clinical Trial Rules 2019 MD bureau10 March 2020 1:50 PM ISTNew Delhi: Aimed at promoting clinical research in the country. Union Health Ministry notified the Drugs and Clinical Trials Rules, 2019 in the month...
World's first drug for treatment of Non-Cirrhotic NASH approved: Zydus Medical Dialogues Bureau6 March 2020 2:26 PM ISTSaroglitazar is uniquely poised with its dual PPAR alpha and gamma properties – reducing the comorbidities (dyslipidemia, hypertriglyceridemia,...
CDSCO pulls manufacturers for failing to submit application for category d FDCs; Details Farhat Nasim14 Feb 2020 12:31 PM ISTNew Delhi: Through a recent notification, the Central Drugs Standard Control Organization (CDSCO) has pulled up the Fixed-Dose Combination (FDCs)...
